DexCom Schedules Conference Call On Monday, October 8, 2012 At 4:30 P.M. Eastern To Discuss G4™ PLATINUM Approval

DexCom, Inc. (NASDAQ:DXCM) today announced that Terry Gregg, CEO, and Kevin Sayer, President, will hold a conference call to discuss FDA’s approval of the company’s G4 PLATINUM continuous glucose monitoring system starting at 4:30 p.m. (Eastern Time) on Monday, October 8, 2012. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor relations, events and webcast section, and will be archived for future reference.

To listen to the conference call, please dial 1 (888) 771-4371 (US/Canada) or 1 (847) 585-4405 (International) and use the confirmation number "33515973" approximately five minutes prior to the start time.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients with diabetes and by healthcare providers in the hospital.

Copyright Business Wire 2010

If you liked this article you might like

These Are the Biggest Winners and Losers in Activist Investing This Year

These Are the Biggest Winners and Losers in Activist Investing This Year

Fundamentals Drive This Rally: Cramer's 'Mad Money' Recap (Thursday 11/16/17)

Fundamentals Drive This Rally: Cramer's 'Mad Money' Recap (Thursday 11/16/17)

Comcast, Lululemon, EQT and Other New Activist Investments

Comcast, Lululemon, EQT and Other New Activist Investments

The Case for the Bears: Cramer's 'Mad Money' Recap (Wed 10/4/17)

The Case for the Bears: Cramer's 'Mad Money' Recap (Wed 10/4/17)

Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus

Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus